Synlico Inc. is a resident company of Johnson & Johnson Innovation – JLABS, a premier life science incubator program. Synlico is at the forefront of transforming biology by leveraging causality to make cellular processes explainable, predictable, and engineerable. Our focus is on developing innovative therapies for oncology and other diseases by employing the latest development in artificial intelligence, causal discovery & inference, and single-cell bioinformatics. Our unique approach lies in unraveling the causal relationships between cells' intracellular activities and their responses in the patients’ heterogeneous microenvironment, predicting how cell modulation alters its behavior in patients. Synlico leverages a causal- and prediction-based approach to navigate the complexities/heterogeneity of diseases.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 329 Oyster Point Boulevard, 3rd Fl, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.synlico.com
- Keywords
- Representative jobs.
- HQ
- South San Francisco, California
Synlico Inc. Questions
Synlico Inc.'s website is http://www.synlico.com
Synlico Inc.'s LinkedIn profile is https://www.linkedin.com/company/synlico-inc
Synlico Inc. has
8 employees.
View email and phone details for 8
employees at Synlico Inc..
Synlico Inc.'s industry is
Biotechnology Research
Synlico Inc.'s top competitors are
Ardence Consulting,
Henlius Usa Inc.,
Crystal Bio Solutions, A Member Of Crystal Pharmatech,
Newlimit,
Acrobat Genomics,
Arcadia Science,
Atomwise,
Viltis,
Huminly,
Dinamo Biotechnologies.
Synlico Inc.'s categories are Biotechnology Research
Synlico Inc.'s founding year is 2021
